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A b s t r a c t  
Homocastasterone is a ketosteroid and a member of the brassinosteroid family of plant hormones. 
Earlier studies with 28-homobrasslinolide, an aldosteroid, had indicated that rat blood and tissue 
biochemical parameters studied were affected by this compound, resulting in altered homeostasis 
and cellular phosphorylation status, rendering this plant oxysterol inappropriate for high energy 
related work activities. The use of the ketosteroid in this study presents evidence for renormalization 
of elevated plasma lipid content in diabetic rat, antiglycemic potency, increase in liver glycogen and 
glucose level and diminished ALT and AST enzyme activities. A role for this ketosteroid in rat liver 
gluconeogenesis and in lipid homeostasis is suggested while the aldo and keto forms regulated 
glucose homeostasis in the rat. The observed differences in the effects of homobrasslinolide and 
homocastasterone as exogenous oxysterols on normal and diabetic rat plasma lipid level suggests 
the possibility of differential influence by endogenous aldo and keto oxycholesterol forms on glucose 
and lipid homeostasis in mammalian physiology.  
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Introduction 
Homocastasterone is a steroid plant hormone, structurally a keto-
isoform, which is an active plant growth regulator among the 
brassinosteroid (Bs) family members. Homocastasterone and 28-
homobrassinolide (aldo-isoform) are actively synthesized in plants 
by CYP72B1 enzyme and contributes to growth regulation, seed 
germination, stress response and photomorphogenesis through 
modulation of cellular signalling processes. Bs role in plants is 
understood based on the outcome of their specific applications in 
agriculture [1]. Bs isoforms have structural similarity with insect 
growth regulators (IGRÊs), and have been shown to affect their egg 
laying capacity, fecundity and longevity among different insects 
groups [2]. Humans and animals are exposed to these hormones, 
through consumption of food. Assimilation of these compounds 
differentially into tissues may induce metabolic stress in animal 
cells. Certain Bs isoforms exhibit structural similarity with 
endogenous oxycholesterols, 7-ketocholesterol, 24-
hydroxycholesterol and 27-hydroxycholesterol, being oxidation 
products of cholesterol through enzymatic (Cyt P450) and non-
enzymatic (ROS) processes in animal tissues. Oxysterols can be 
endogenous (tissue based) and exogenous origins (of plant and 
insects) [3, 4]. Their levels are very low in tissues, and they exhibits 
biological potency by acting through nuclear orphan receptors, 
namely the liver x receptor (LxR). LxR are considered as potentially 
regulating cholesterol, triglyceride and glucose homeostasis, 
through nuclear signaling and transcriptional regulation of cellular 
catalytic activities. Recently LxR has been recognised as drug 
target for hyperglycaemic and atherosclerosis conditions [5]. Yet till 
date, plant oxysterol effects on LxRs remain little studied while 
identification of potent LxR ligands from natural sources remains 
an exciting possibility.  
We have previously reported the effect of the plant aldosteroid 28-
homobrassinolide, in diabetic rat model, as exhibiting altered tissue 
enzyme activity and hexokinase gene expression. Improvement in 
tissue architecture and reduced lipid peroxidation concomitant with 
improved antioxidant status was noted in the study [6-9]. However, 
these studies indicated elevation of blood cholesterol and 
triglyceride in the experimental animal though blood glucose level 
was found to be regulated. Recently, a steroidogenesis promoting 
effect of 28-HB through elevation of StAR protein and ABP in rat 
testis was reported [10]. However, 28-HB did not reduce 
blood/plasma levels of triglyceride and cholesterol. Nevertheless, 
28-HB caused changes in tissue histology and tissue marker 
enzyme activity in the rat. The anabolic effect of brassinosteroids, 
its anticancer activity in human cancer cell line, beneficial effects 
on high fat-induced diabetic mice, improved insulin sensitivity and 
reduced gluconeogenesis have also been reported earlier [11].     
Search for a natural product that did not raise blood lipid level 
when administered for countering hyperglycaemia, therefore led us 
to investigate the biopotency of the ketosteroid- homocastasterone 
(HC), as an alternate compound for the investigation, employing 
normal and STZ induced diabetic male rat to understand its impact 
on lipid and carbohydrate metabolism while monitoring plasma and 
tissue bio markers to assess specific biological responses.    
Material and Methods 
Chemicals, Reagents and Experimental rat 
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All chemical used in this study were analytical grade purchased 
from Sigma Aldrich (USA). Homocastasterone was gifted by Dr. 
V.S. Pori, NCL, Pune, India. Blood diagnostic Kits were purchased 
from Agape diagnostics, Kerala, India. Rats were purchased from 
the authorised dealer Sri Ragavendra Enterprises, Bangalore, 
India, and were maintained at 22■C with 12hr light/dark cycle and 
were given normal standard chow and water ad libitum, throughout 
the experimental period. Following one week of acclimatisation, 24 
healthy, normal, 6-8 week old rats weighing 150-180gm were 
selected for the study. Rats were divided into four groups and each 
group contained 6 rats. Animal use and care was strictly followed 
as per CPCSEA regulations and Institutional Animal Ethics 
Committee (IAEC) guidelines. The animals were segregated into 
four groups. Such as, 
Group I:    Normal control 
Group II:   Normal + Homocastasterone treated  
Group III:  Diabetic Control 
Group IV:  Diabetic + Homocastasterone treated 
Induction of diabetes 
Diabetes was induced by a single intraperitoneal injection of 60 
mg/kg bwtstreptozotocin in citrate buffer (0.1 M, pH 4.5) to 
overnight fasted rat. A 5% glucose solution was given to the STZ 
injected rats to prevent hypoglycemic death due to use of STZ. 
After 48hr, tail vein blood was collected from the animal and the 
glucose level was measured with the help of a glucometer. 
Glucose content greater than 250 mg/dL was considered diabetic, 
for use in the experiments. 
Homocastasterone treatment 
Groups II and IV received 666 mg/ kg bwt HC in 50% ethanol by 
oral gavage for 15 consecutive days and Control groups I and III 
received 50% ethanol alone. 
Blood and organ collection for assay 
At the end of 15 days, rats were euthanized and blood collected by 
cardiac puncture into heparinised tubes, centrifuged at 1000 rpm 
for 10 minutes in a clinical centrifuge and plasma collected and 
stored at -20■C until analysis. Tissues were removed immediately, 
washed with phosphate buffer (0.1M pH 7.4) thoroughly and stored 
in phosphate buffer at -80■C for further analysis. 
Determination of plasma biomarkers  
Glucose, cholesterol, triglycerides, HDL, urea, creatinine, and uric 
acid, ALT, AST and LDH were analysed employing the kit method 
as per manufacturerÊs instruction. 
Analysis of tissue biomarkers 
Sliced portion of tissues were weighed (1g) and washed with ice 
cold saline (0.9% NaCl), and homogenized (10% w/v) in 10ml of 
0.1M phosphate buffer pH 7.4 with help of a Potter-Elvehjem 
Teflon homogenizer followed by centrifugation at 3000x g for 30min 
at 10oC in a refrigerated eppendorf centrifuge. The supernatant 
was collected and was used for the determination of biochemical 
parameters such as cholesterol, triglycerides and urea, by the kit 
method. Total protein content in the homogenate was estimated by 
the method of Lowry [12]. 
Tissues glycogen and glucose estimation 
200 mg of tissue was taken in 20 ml 5% TCA solution and 
homogenized with the help of a Potter-Elvehjem Teflon 
homogenizer. After centrifugation at 6000 rpm for 10 minutes in a 
refrigerated eppendorf centrifuge, the clear supernatant was 
collected for glycogen assay. 2 ml of supernatant and 3 ml the 
lugolÊs reagent were mixed thoroughly and the colour developed 
was measured for glycogen content at 650 nm [13]. Values were 
expressed as mg/gm tissue. Liver glucose was assayed by the O-
toludine method [14].  
Histological of rat liver for glycogen content 
5 øm sections of rat liver were prepared as paraffin embedded liver 
blocks with the help of a digitalized microtome and standard PAS 
staining procedure was adopted to stain these sections. 
Photomicrographs of the stained sections (100x) were taken with 
the aid of camera and attached to a binocular microscope [15].  
Statistical analysis 
Results were expressed as mean μ SD, and the data was analysed 
by one way ANOVA. Following this, Post doc test was used 
employing SPSS software 16.0 version. A value of p < 0.05 was 
considered significant. 
Result 
The specific biological effect observed in rat plasma and in 
selected rat tissues due to the plant ketosteroid homocastasterone 
is detailed below.   
On plasma studies 
Administration of rat by oral gavage with homocastasterone for 15 
days reduced rat plasma glucose level from 277 mg/ dL to 165 
mg/dL in the diabetic animal indicating 40% reduction plasma 
glucose in the treated group. 
Plasma cholesterol level reduced from 96 mg/dL to 64mg/dL in the 
HC treated group registering a 31.5% reduction. A decrease (110 
mg/dL to 74 mg/dL) in plasma TG level was noted in diabetic 
treated rat group corresponding to 32.7% reduction while 9.8% in 
TG level in the normal rat treated group was noted. 
Elevated LDL and VLDL levels noted in the diabetic rat group 
reversed after oral treatment with HC. In diabetic treated group the 
LDL level reduced from 33 mg/dl to 18 mg/dL, exhibiting 44.8% 
reduction. VLDL level decreased from 22mg/dL to 14mg/dL 
corresponding to 32.7% reduction. There was no change in the 
plasma HDL level. 
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Table 1. Plasma glucose and lipid in normal and diabetic HC treated rats. 
 
These biomarkers were analysed by the kit method. Values are expressed μ SD mg/dL and mean of three determinations. Statistical significance is indicated 
where p<0.05*. 
 
Elevated level of ALT (165U/dL) in diabetic group, after treatment 
with homocastasterone, was restored to near normal (32 U/dL) 
control, a reduction of 80.6%. Normal treated group also showed 
an 80% reduction in ALT enzyme level compared to the controls. 
Increase in AST level in STZ treated diabetic group, was restored 
to near normal level the 17.8% to the following HC treatment. In 
normal treated group, a 3% in the enzyme activity was seen 
compared to control rat group. 
 
Table 2. Tissues marker enzyme ALT, AST and LDH level in plasma in normal and diabetic HC treated rats. 
 
Plasma enzymes were analysed by kit method. Values are expressed μ SD IU/ l and mean of a three determinations.  
Statistical significance is indicated where p<0.05*. 
 
Plasma urea level in diabetic rat increased three fold compared to 
that of normal rat (46 into 113 mg/dL) but reduced 24.7% for the 
HC treated group. There was no significant change in plasma urea 
level in homocastasterone treated normal group. Significant 
changes were not seen in uric acid level in normal and diabetic 
homocastasterone treated groups. Increased creatinine level in 
diabetic rat was restored to near normal following HC treatment, 
yielding a 28.5% reduction. There is no change seen in normal 
homocastasterone treated group. Albumin decreased 3.5 to 2.8 
mg/dL in the diabetic group compared to control. No significant 
change was observed in normal and diabetic rat groups treated 
with HC. 
 
 
 
Table 3. Plasma renal biomarker parameters in normal and diabetic HC treated rats. 
 
  Renal markers were analysed by kit method. Values are expressed μ SD IU/l and mean of three determinations. 
       Statistical significance is indicated where p<0.05*. 
 
On tissues studies 
Reduction in cholesterol level (Table 4)  was seem in the liver, 
heart and kidney of diabetic treated rat group by 35.5%, 65% and 
55.54% respectively. In the normal treated group, a reduction of 
15% in liver, 51% in heart and 23% in kidney of cholesterol was 
noted. In testis of diabetic treated rat group, cholesterol level 
increased (7.65 to 9.22 mg/dL) 20.5% compared to the control 
group. There was no change in cholesterol level of normal treated 
rat group. In brain however, cholesterol level increased 60% in 
normal treated group compared to control (9.56 to 15.31 mg/dL). 
There was no significant change in brain cholesterol in diabetic 
treated group. 
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Table 4. Tissue lipids, total protein and urea in diabetic and normal HC treated rats. 
 
 Table 4.Liver, heart, kidney, testis, brain tissues cholesterol, triglyceride, total protein and urea levels were analysed in diabetic and normal HC 
treated rats by kit method. Total protein was estimated by Lowry method. Values are expressed μ SD mg/dL and mean of  
      three determinations. Statistical significance is indicated where p<0.05*.  
 
Similarly the triglyceride level in liver, heart, kidney, testis and brain 
of the diabetic rat increased compared to control. However 
triglyceride level reduced in diabetic treated group compared to 
diabetic control liver (20%), heart (45%), kidney (34%), testis 
(51%), and brain (50%). In normal HC treated group, triglyceride 
level in liver, heart and brain reduced by 8%, 66%, and 32% 
respectively. However, twofold increase in triglyceride level was 
seen in testis of normal treated group compared to control. In 
normal HC treated rat group, significant increase in total protein 
level was noticed in the liver (25%), kidney (14%), testis (15%) and 
brain (62%) compared to normal control.  
In the diabetic treated rat, protein level increased in testis (61.55%) 
than liver (4%) and brain (15%) compared to diabetic control. In the 
diabetic treated rat tissue urea level was noted to be reduced, in 
liver, heart, kidney and testis registered are 18, 37, 44, 19% 
compared to diabetic control. There was no significant change in 
brain urea level in the diabetic treated and diabetic control rat 
group. Normal treated rat tissue urea level reduced 18% in liver, 
41% in kidney, 36% in testis and 22% in brain compared to control. 
A 50% reduction (Table 5) in glycogen level in diabetic rat group 
was also noted compared to normal control. However in 
homocastasterone treated diabetic rat group, the liver glycogen 
level increased by 233% compared to control. In normal treated rat, 
liver glycogen level increased 133% compared to control. Liver 
glucose content reduced significantly in diabetic rat. In diabetic 
treated rat however, liver glucose level increased 120% compared 
to control. In normal treated group, liver glucose level increased 
26% (160 mg/dL to 202 mg/dL) compared to control. 
PAS stained sections of diabetic control rat liver showed few PAS 
positive glycogen granules in hepatocytes compared to normal 
control (Figure 1c). For the diabetic treated group, however many 
of the hepatocytes were filled with PAS positive glycogen granules. 
Homocastasterone treated normal rat liver showed increased 
hepatic lobules packed with glycogen granules compared to control 
(Figure 1b). 
 
Table 5. Liver glycogen and glucose content in normal and diabetic 
HC treated rats. 
Groups Glycogen mg/g tissue Glucose mg/g tissue
Normal control 1.000 μ 0. 0.27 160.0 μ 8.41
Normal +  HC 2.333 μ0.25 * 202.8 μ 6.57*
Diabetic Control 0.500 μ 0.18 42.81 μ 5.47
Diabetic +  HC 1.666 μ0.35 * 94.24 μ 6.73*
Liver biomarkers were analysed as described in methods. Values are expressed μ 
SD mg/g tissue and mean of six determinations. Statistical significance is indicated 
where p<0.05*.  
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(a) Normal control                                                     (b) Normal + HC 
 
(b) Diabetic control                                                    (d) Diabetic + HC 
 
Figure 1. PAS staining of liver section for glycogen granules in diabetic and normal HC treated rat (100x). 
(a) Normal control shows hepatocytes filled with PAS positive glycogen, (b) Normal + HC treated groups shows most of the hepatic lobules packed with 
glycogen, (c) Diabetic control very few hepatocytes shows, few granules of PAS positive glycogen granules in cytoplasm, (d) Diabetic + HC treated group shows 
majority of hepatocytes are filled with PAS positive glycogen granules. 
 
Discussion 
Diabetes was established in the experimental rat blood employing 
streptozotocin at 60mg/kg bwt (blood glucose <250 mg/dL). Both 
normal as well as the diabetic rats were orally fed 
homocastasterone for 15 consecutive days thereafter at 666 øg/kg 
bwt. Following administration of this ketosteroid, blood glucose 
level determined was found to be different for the control and 
treated animals. HC treated animals yielded lower blood glucose 
level than their control counterpart. Similar results were noted 
earlier from this lab using 28-homobrassinolide through the work of 
Muthuraman and Srikumar [6,7,9]. In the present study, it was 
noted that liver content of glycogen increased following HC 
treatment of the diabetic animal while concomitantly observing 
reduction in blood glucose level, indicative of increasing liver stores 
of this sugar. Histological section of the HC treated diabetic rat liver 
confirmed this finding, indicating increased liver glycogen 
synthesis. 
The use of 28-HB in earlier studies had noted increased plasma 
cholesterol and triglyceride in the experimental normal and diabetic 
rat. Such physiological responses promote the use of 28-HB as a 
potent antihyperglycemic factor. Surprisingly, the use of the plant 
ketosteroid HC resulted in renormalizing the elevated lipid content 
of diabetic rat plasma. The observed difference in the potential to 
increase plasma lipid content by 28-HB in normal and diabetic rat 
versus the potential to renormalize the elevated lipid content of 
diabetic rat plasma by HC leads us to suggest that lipid 
homeostasis in this mammalian model is under regulation by aldo- 
keto isomeric states of endogenous oxysterols, whereas the 
potential to regulate glucose homeostasis remained common to 
both chemical forms. 
Liver marker enzyme ALT and AST levels increased in the blood of 
STZ induced diabetic rat. These enzymes are present in high 
amounts in the liver and have a role in supplying intermediates for 
gluconeogenesis through transamination reactions. ALT and AST 
are there for diagnostically important in liver damage. In diabetic 
animals increased ROS production caused hepatocyte membrane 
damage and release of the enzymes into circulating blood [16]. 
Alteration in liver function in diabetes causes significant increase in 
these enzymes in the plasma of the diabetic subject. Oral 
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administration of homocastasterone for 15 consecutive days to 
normal and diabetic rat yielded dramatically reduced ALT and AST 
enzyme levels in rat plasma compared to their respective controls. 
The observed reduction in plasma ALT and AST levels by HC is 
indicative of reduced release of these marker proteins from 
hepatocytes simultaneous with protection of membrane 
injury[17].Increase in the ALT enzyme level noted in diabetic 
control rat was renormalized by treatment of the animal with this 
phytohormone. 
In STZ induced diabetic control rat plasma urea and creatinine 
levels were (Table 3) significantly increased compared to that in 
normal control.  This effect in the diabetic rat is a consequence of 
increased protein breakdown and impaired renal function. In the 15 
day ketosteroid treated diabetic group, significant reduction of 
blood urea level were noted compared to that in control group, 
while there was no change observed in the normal treated group. 
Esposito et al (2012) had reported antihyperglycemic effect of 28-
HB in high fat diet-induced obese mice. Esposito et al (2011) also 
reported that plant 28-HB had anabolic effect in mammalian 
system [11,18].Improvement in renal structure and function 
therefore contributed to decreased urea and creatinine levels. The 
observed decrease in plasma level of these compounds therefor 
suggested that the administered plant ketosteroid improved rat 
renal architecture and function. 
Plasma albumin and total protein presented in table 3, shows 
reduced level of these markers in diabetic rat compared to control. 
Diabetic rat treated with homocastasterone showed no significant 
changes. 
This study attempts to understand the keto-steroid effect on lipid 
profile in rat plasma and in selected rat tissues such as the liver, 
testis, heart, brain and kidney (Table 4). Cholesterol and 
triglyceride levels increased significantly in the diabetic control rat 
compared to the normal control rat. This observation is similar to 
those of the others [19,20].Diabetes induced lipolysis and lipid 
mobilization from adipose tissues. Abnormal synthesis of 
cholesterol and triglycerides is also reported in diabetes and 
contributes to enhanced lipid profile in diabetic tissues. Following 
oral administration of homocastasterone to normal and diabetic rat, 
statistically significant decrease in the level of cholesterol and 
triglycerides in the liver, heart, kidney and testis were 
experimentally observed in our study. 
In the STZ induced diabetic rat (Table 4) elevated urea level and 
decreased protein level in liver and testis were noted compared to 
normal control. These marker changes may due to the increased 
tissue protein breakdown and impaired renal function in diabetic rat 
[20-22]. In HC treated rat tissues, however urea level reduced 
significantly compared to the control and increased protein level 
was noted in liver, kidney and testis after oral administration of HC 
to the normal and diabetic rat. Increase in protein suggests 
anabolic effect by homocastasterone.  
 Conclusion 
Several studies carried out in the past on the effect of the 
brasslinolide family of phytohormones in normal and different 
diabetic mammalian models have shown beneficial effects in terms 
of antihyperglycemic, antihyperlpidemic and anabolic effects. This 
lab has previously reported that 28-homobrasslinolid an aldo-form 
of brasslinolide has antihyperglycemic potency, but caused 
elevation of cholesterol and triglycerides level in plasma. The 
present study demonstrates that homocastasterone, a keto-form of 
the brasslinolide, caused significant reduction in plasma and tissue 
cholesterol and triglyceride level, but retained the 
antihyperglycemic potency in diabetic rats on 15 days treatment. 
Further work is underway to address the mechanism of the action 
of this phytohormone on lipid lowering effect.  
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